All Stories

  1. High-sensitive cardiac troponin after CPAP in obstructive sleep apnoea: the adjusted analytical change limit (adjACL) for small variations at low concentrations

    Article • European Respiratory Journal, January 2022, European Respiratory Society (ERS)

    Dr Denis Monneret

  2. Non-linearity and gaps in results distribution over successive Roche Lipase method applications: improvement but persistence

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2019, Taylor & Francis

    Dr Denis Monneret

  3. Outlier removal methods for skewed data: impact on age-specific high-sensitive cardiac troponin T 99th percentiles

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2019, De Gruyter

    Dr Denis Monneret

  4. N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on cardiac function in obstructive sleep apnea

    Article • F1000Research, November 2018, Faculty of 1000, Ltd.

    Dr Denis Monneret

  5. Estimated GFR-specific 99th percentiles for high-sensitive cardiac troponin T based on the adjusted analytical change limit (adjACL) in hospitalized patients

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2018, De Gruyter

    Dr Denis Monneret

  6. Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, May 2018, Taylor & Francis

    Dr Denis Monneret

  7. Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), November 2017, De Gruyter

    Dr Denis Monneret

  8. Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations

    Article • F1000Research, September 2017, Faculty of 1000, Ltd.

    Dr Denis Monneret

  9. Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension

    Article • International Journal of Cardiology, July 2017, Elsevier

    Dr Denis Monneret

  10. Introducing High-Sensitivity Cardiac Troponin T as a Biomarker of OSA-Related Cardiovascular Morbidity in Obesity Hypoventilation Syndrome

    Article • CHEST Journal, December 2016, Elsevier

    Dr Denis Monneret

  11. Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects

    Article • Experimental Physiology, October 2016, Wiley

    Dr Denis Monneret, Anne Briançon-Marjollet

  12. Analytical Performance Requirements for Biomarker-based Studies Evaluating Continuous Positive Airway Pressure Effects in Obstructive Sleep Apnea

    Article • American Review of Respiratory Disease, August 2016, American Thoracic Society

    Dr Denis Monneret

  13. Potassium as a potential predictive biomarker of brain hypoxia in avalanche victims: preanalytical recommendations

    Article • The American Journal of Emergency Medicine, July 2016, Elsevier

    Dr Denis Monneret

  14. Plasma endothelin-1 in acute heart failure: pathophysiological and preanalytical considerations

    Article • European Journal of Heart Failure, April 2016, Wiley

    Dr Denis Monneret

  15. Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA

    Article • European Respiratory Journal, February 2016, European Respiratory Society (ERS)

    Dr Denis Monneret

  16. Stability of Routine Biochemical Analytes in Whole Blood and Plasma From Lithium Heparin Gel Tubes During 6-hr Storage

    Article • Journal of Clinical Laboratory Analysis, February 2016, Wiley

    Dr Denis Monneret

  17. Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase

    Article • The Journal of Physiology, January 2016, Wiley

    Dr Denis Monneret, Anne Briançon-Marjollet

  18. Comparison of a 10- vs. 15-min centrifugation time for chemical and immunochemical assays and impact on turnaround time in a hospital laboratory

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Dr Denis Monneret

  19. High-Sensitivity Cardiac Troponin T: a Preanalytical Evaluation

    Article • Clinical Laboratory, January 2016, Clinical Laboratory Publications

    Dr Denis Monneret

  20. Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase

    Article • September 2015, European Respiratory Society (ERS)

    Dr Denis Monneret

  21. Evaluation of HbA1c as a prognostic biomarker of cardiovascular events and mortality in nondiabetic patients: Methodological considerations

    Article • Atherosclerosis, September 2015, Elsevier

    Dr Denis Monneret

  22. Letter by Monneret et al Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”

    Article • Circulation Heart Failure, September 2015, Wolters Kluwer Health

    Dr Denis Monneret

  23. Bicarbonate or Base Excess in Early Obesity Hypoventilation Syndrome

    Article • CHEST Journal, June 2015, Elsevier

    Dr Denis Monneret

  24. Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: Determination of allowable interference limits according to different calculation methods

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2015, Informa Healthcare

    Dr Denis Monneret

  25. Comparison of measured venous carbon dioxide and calculated arterial bicarbonates according to the PaCO2 and PaO2 cut-off values of obesity hypoventilation syndrome

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Dr Denis Monneret

  26. S100B protein concentration measurement according to two different immunoassays

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Dr Denis Monneret

  27. Isoprostane as a promising prognostic biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints

    Article • International Journal of Cardiology, December 2014, Elsevier

    Dr Denis Monneret

  28. Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”

    Article • Clinics and Research in Hepatology and Gastroenterology, September 2014, Elsevier

    Dr Denis Monneret, Thierry Poynard

  29. Analytical comparison of the new point-of-care troponin T immunoassay on AQT90Flex® analyzer (Radiometer) and the high-sensitivity troponin T immunoassay on ModularE170® (Roche Diagnostics)

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Denis Monneret

  30. The Severity of Nocturnal Hypoxia but Not Abdominal Adiposity Is Associated with Insulin Resistance in Non-Obese Men with Sleep Apnea

    Article • PLoS ONE, August 2013, PLOS

    Dr Denis Monneret

  31. Independent Association of Urinary F2-Isoprostanes With Survival in Pulmonary Arterial Hypertension

    Article • CHEST Journal, October 2012, Elsevier

    Dr Denis Monneret, Professor Olivier SITBON

  32. Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD

    Article • Respiratory Physiology & Neurobiology, August 2012, Elsevier

    Dr Denis Monneret

  33. Altitude illness is related to low hypoxic chemoresponse and low oxygenation during sleep

    Article • European Respiratory Journal, April 2012, European Respiratory Society (ERS)

    Dr Denis Monneret

  34. Obesity hypoventilation syndrome: From sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies

    Article • Respirology, April 2012, Wiley

    Dr Denis Monneret

  35. Noninvasive Ventilation in Mild Obesity Hypoventilation Syndrome

    Article • CHEST Journal, March 2012, Elsevier

    Dr Denis Monneret

  36. Corticosteroid after etomidate in critically ill patients

    Article • Critical Care Medicine, January 2012, Wolters Kluwer Health

    Dr Denis Monneret

  37. The Impact Of Obstructive Sleep Apnea On Homocysteine And Carotid Remodelling In Patients With Metabolic Syndrome

    Article • May 2011, American Thoracic Society

    Dr Denis Monneret

  38. High-Altitude Illness And Hypoxic Chemoresponsivness: A Unifying View Of Individual Susceptibility

    Article • May 2011, American Thoracic Society

    Dr Denis Monneret

  39. Cardiovascular And Metabolic Consequences Of Chronic Intermittent Hypoxia In Lean Versus Obese Zucker Rats

    Article • May 2011, American Thoracic Society

    Dr Denis Monneret

  40. Effects Of CPAP And Valsartan Randomly Assigned On Baroreflex Function And Aldosterone In Hypertensive OSAS

    Article • May 2011, American Thoracic Society

    Dr Denis Monneret

  41. Association Of Urinary 15-F2t-isoprostane Level With Oxygen Desaturation And Carotid Intima-media Thickness In Non-obese Sleep Apnea Patients

    Article • May 2010, American Thoracic Society

    Dr Denis Monneret

  42. One-month Of Non-Invasive Ventilation In Obesity Hypoventilation Syndrome Improves Sleep Architecture And Blood Gazes But Has No Impact On Inflammatory, Metabolic And Cardiovascular Status: A Randomized Controlled Trial

    Article • May 2010, American Thoracic Society

    Dr Denis Monneret

  43. Pleiotropic role of IGF-I in obesity hypoventilation syndrome

    Article • Growth Hormone & IGF Research, April 2010, Elsevier

    Dr Denis Monneret

  44. Significant Improvement in Arterial Stiffness After Endurance Training in Patients With COPD

    Article • CHEST Journal, March 2010, Elsevier

    Dr Denis Monneret

  45. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima–media thickness in nonobese sleep apnea patients

    Article • Free Radical Biology and Medicine, February 2010, Elsevier

    Dr Denis Monneret

  46. ENDOTHELIAL DYSFUNCTION AND SPECIFIC SYSTEMIC INFLAMMATION IN OBESITY HYPOVENTILATION SYNDROME

    Article • CHEST Journal, October 2009, Elsevier

    Dr Denis Monneret

  47. Endothelial Dysfunction and Specific Inflammation in Obesity Hypoventilation Syndrome

    Article • PLoS ONE, August 2009, PLOS

    Dr Denis Monneret